Analyst Upgrades: Anadarko Petroleum Corporation, Kate Spade & Co, and UnitedHealth Group Inc

Analysts upwardly revised their ratings and price targets on Anadarko Petroleum Corporation (APC), Kate Spade & Co (KATE), and UnitedHealth Group Inc (UNH)

by Alex Eppstein

Published on Sep 13, 2016 at 10:20 AM

Analysts are weighing in on oil-and-gas stock Anadarko Petroleum Corporation (NYSE:APC), accessories designer Kate Spade & Co (NYSE:KATE), and insurance giant UnitedHealth Group Inc (NYSE:UNH). Here's a quick roundup of today's bullish brokerage notes on APC, KATE, and UNH.

  • APC is down 2.4% at $56.40, in the wake of its $2 billion Gulf asset purchase, which will largely be funded by a secondary offering of 35.3 million shares. Failing to give the stock a boost are price-target hikes at RBC (to $70) and Morgan Stanley (to $81). While Anadarko Petroleum Corporation is struggling today, it's been making a series of higher highs and lows since bottoming in January at $28.16 -- doubling in value over that time. Not surprisingly, the analyst community has grown bullish toward the stock, which sports 15 "buy" or better recommendations, compared to five "holds" and just a single "sell" opinion.
  • Wells Fargo upgraded its rating on KATE to "outperform" from "market perform," boosting the stock 3.1% to $18.95. However, the shares have been struggling since their late-April highs north of $26, and are approaching a recent layer of resistance at their 40-day moving average. Accordingly, options traders have been placing bearish bets over bullish at an extreme rate in recent months. Kate Spade & Co's 50-day put/call volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) registers at an annual high of 1.21.
  • UNH has shed 1.4% at $133.67, despite being named a "top pick" at Jefferies -- which cited confidence in the company's management and an attractive valuation. Separately, UnitedHealth Group Inc's Optum unit announced a partnership with Quest Diagnostics Inc (NYSE:DGX). Technically speaking, UNH is up more than 13% year-to-date, but recently was turned back in the $140-$145 zone after a period of consolidation. As a whole, the brokerage bunch has sky-high expectations for the stock. Sixteen analysts rate UNH a "buy" or better, versus just a single "hold" opinion and one "strong sell."
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Planet Fitness Stock Lifted Amid Re-Opening Optimism
Planet Fitness reopened around 800 facilities in North America
Coffee Stock Drops Despite Cost-Cutting Initiatives
Starbucks asked employees to further limit working hours or take unpaid leave
The Big Bankruptcy You Should Be Afraid Of
Porter Stansberry is making a concerning prediction.